Le Lézard
Classified in: Health
Subjects: CCA, FVT

Envista Announces Virtual Participation In September Healthcare Conferences

BREA, Calif., Aug. 31, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2020 Global Healthcare Conference on Wednesday, September 9, 2020. Amir Aghdaei, President and Chief Executive Officer, will present during Session III from 10:50 ? 11:20 AM ET.

Envista also announced that the company will participate in the Morgan Stanley 18th Annual Global Healthcare Conference on Wednesday, September 16, 2020. Amir Aghdaei, President and Chief Executive Officer, will present from 4:15 ? 4:45 PM ET.

Investors will be able to access both events through Envista's Investor Relations website under the subheading Events and Presentations.

Envista is a global family of more than 30 trusted dental brands, united by a shared purpose: to partner with professionals to improve lives.  Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services.  Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers an estimated 90% of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile.  Envista companies, including KaVo, Kerr, Nobel Biocare, and Ormco, partner with dental professionals to help them deliver the best possible patient care.

Envista separated from Danaher Corporation and became an independent company in 2019. We brought with us the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus to meet the end-to-end needs of dental professionals worldwide.  Envista is now one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry.  For more information, please visit www.envistaco.com.

John Bedford
Vice President, Investor Relations
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Brea, CA 92821
Telephone: (714) 817-7000
Fax: (714) 817-5450

SOURCE Envista Holdings Corporation

These press releases may also interest you

at 16:40
Aflac Incorporated , a Fortune 200 company that helps provide protection to more than 50 million people in Japan and the U.S., and Trupanion, Inc. , a leader in medical insurance for cats and dogs, are pleased to have entered into an exclusive...

at 16:35
Geron Corporation today announced that it will release its third quarter 2020 financial results after the market closes on Thursday, November 5, 2020 via press release, which will be available on the Company's website at www.geron.com/investors....

at 16:35
Opal Apples, the only naturally non-browning, non-GMO apples grown in the U.S., today announced the launch of its Crave the Crunch campaign to officially kick off Opal season. The nationwide campaign, which rolls out this month, will seek to...

at 16:30
Rafael Holdings, Inc., , reported revenue of $4.9 million and a loss per share of $0.66 for the fiscal year ended July 31, 2020. Fourth quarter revenue was $1.2 million with a loss per share of $0.34. Q4 FY 2020 Consolidated Highlights Revenue of...

at 16:30
Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") today announced results for its third quarter ended September 30, 2020. For the third quarter ended September 30, 2020, net operating revenues increased 2.2% to $1,423.9...

at 16:30
Protagonist Therapeutics, Inc. today announced that two additional oral peptide IL-23 receptor antagonist candidates from its collaboration agreement with Janssen Biotech, Inc., have been selected for advancement into clinical development. The two...

News published on 31 august 2020 at 16:01 and distributed by: